{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:04:01Z","timestamp":1790370241000,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011915","name":"Taylor\u2019s University","doi-asserted-by":"publisher","award":["Taylor\\u2019s Research Scholarship (TRES) Program"],"award-info":[{"award-number":["Taylor\\u2019s Research Scholarship (TRES) Program"]}],"id":[{"id":"10.13039\/501100011915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.vhri.2026.101689","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:55:09Z","timestamp":1790020509000},"page":"101689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survey and Patient-Reported Outcome Measure Instruments for Assessing Out-of-Pocket Costs and Financial Toxicity in Cancer Care: A Systematic Review"],"prefix":"10.1016","volume":"57","author":[{"given":"Samantha Y.W.","family":"Foo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Sheng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annushiah Vasan","family":"Thakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008-2030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.vhri.2026.101689_bib2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S1470-2045(24)00516-3","article-title":"Rising costs of cancer medicines","volume":"25","author":"Devi","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vhri.2026.101689_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102864","article-title":"Health inequalities in cancer care: a literature review of pathways to diagnosis in the United Kingdom","volume":"76","author":"Scott","year":"2024","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.vhri.2026.101689_bib4","article-title":"Cancer disparities in Southeast Asia: intersectionality and a call to action","volume":"41","author":"Feliciano","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35590","article-title":"Global disparities in cancer care: bridging the gap in affordability and access to medications between high and low-income countries","volume":"131","author":"Tfayli","year":"2025","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.vhri.2026.101689_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70593","article-title":"Assessing the economic impact of cancer care: a study on out-of-pocket expenditures and utilization in South Korea","volume":"14","author":"Kim","year":"2025","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib7","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1186\/s12913-025-13723-4","article-title":"Magnitude of catastrophic health expenditure and its determinants among cancer patients in low and middle-income countries: a systematic review and meta-analysis","volume":"25","author":"Kaso","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s41669-022-00371-1","article-title":"Healthcare costs before and after diagnosis of cancer of unknown primary versus ovarian cancer in Australia","volume":"7","author":"Gordon","year":"2023","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1186\/s12913-022-08457-6","article-title":"Increased healthcare costs by later stage cancer diagnosis","volume":"22","author":"McGarvey","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vhri.2026.101689_bib10","article-title":"Cancer care disparities: overcoming barriers to cancer control in low- and middle-income countries","volume":"10","author":"Bamodu","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.vhri.2026.101689_bib11","first-page":"1449","article-title":"Cancer-related costs, the resulting financial impact and coping strategies among cancer survivors living in a setting with a pluralistic health system: a qualitative study","volume":"16","author":"Noorulain","year":"2022","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"10.1016\/j.vhri.2026.101689_bib12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/curroncol28020117","article-title":"The out-of-pocket cost burden of cancer care\u2014A systematic literature review","volume":"28","author":"Iragorri","year":"2021","journal-title":"Curr Oncol"},{"issue":"10","key":"10.1016\/j.vhri.2026.101689_bib13","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/hed.26801","article-title":"The cost of cure: examining objective and subjective financial toxicity in head and neck cancer survivors","volume":"43","author":"Baddour","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.vhri.2026.101689_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104521","article-title":"Patient-reported financial toxicity and adverse medical consequences in head and neck cancer","volume":"101","author":"Beeler","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.vhri.2026.101689_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211009252","article-title":"Economic burden of cancer on cancer patients treated at Hawassa University comprehensive specialized hospital","volume":"28","author":"Bona","year":"2021","journal-title":"Cancer Control"},{"issue":"12","key":"10.1016\/j.vhri.2026.101689_bib16","first-page":"7355","article-title":"Association of Co-morbidities with financial hardship in survivors of adult cancer","volume":"29","author":"Fastiggi","year":"2021","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s41043-025-01033-8","article-title":"Economic burden and quality of life caused by non-Hodgkin lymphoma cancer in Iran","volume":"44","author":"Ghiasi","year":"2025","journal-title":"J Health Popul Nutr"},{"issue":"3","key":"10.1016\/j.vhri.2026.101689_bib18","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1016\/S2214-109X(21)00595-7","article-title":"Out-of-pocket payments for complementary medicine following cancer and the effect on financial outcomes in middle-income countries in Southeast Asia: a prospective cohort study","volume":"10","author":"Kong","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.vhri.2026.101689_bib19","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.31557\/APJCP.2021.22.12.3755","article-title":"Economic burden of cancer treatment in a region in South India: a cross sectional analytical study","volume":"22","author":"Maurya","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"10.1016\/j.vhri.2026.101689_bib20","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.31557\/APJCP.2022.23.5.1611","article-title":"Household catastrophic health expenditure from oral potentially malignant disorders and oral cancer in public healthcare of Malaysia","volume":"23","author":"Raman","year":"2022","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s11764-022-01293-x","article-title":"Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany: a multi-regional population-based study","volume":"17","author":"Schneider","year":"2023","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.vhri.2026.101689_bib22","article-title":"Socio-economic and rural-urban differences in healthcare and catastrophic health expenditure among cancer patients in China: analysis of the China health and retirement longitudinal study","volume":"9","author":"Zhao","year":"2021","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.vhri.2026.101689_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2013-0374","article-title":"Self-reported financial burden and satisfaction with care among patients with cancer","volume":"19","author":"Chino","year":"2014","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.vhri.2026.101689_bib24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.vhri.2026.101689_bib25","first-page":"153","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.vhri.2026.101689_bib26","first-page":"7159","article-title":"Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis","volume":"30","author":"Donkor","year":"2022","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13690-025-01738-6","article-title":"The economic burden of lung cancer in low- and lower-middle-income countries: a systematic review","volume":"83","author":"\u00dcnal","year":"2025","journal-title":"Arch Public Health"},{"issue":"5","key":"10.1016\/j.vhri.2026.101689_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv410","article-title":"Minimizing the \u201cfinancial toxicity\u201d associated with cancer care: advancing the research agenda","volume":"108","author":"Tucker-Seeley","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.vhri.2026.101689_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.vhri.2026.101689_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-017133","article-title":"The financial toxicity of cancer: unveiling global burden and risk factors\u2014a systematic review and meta-analysis","volume":"10","author":"Kitaw","year":"2025","journal-title":"BMJ Glob Health"},{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjon.2022.04.010","article-title":"A systematic review of financial toxicity among cancer patients in China","volume":"9","author":"Xu","year":"2022","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"2","key":"10.1016\/j.vhri.2026.101689_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55388","article-title":"Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis","volume":"6","author":"Ehsan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vhri.2026.101689_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2025.100581","article-title":"Research on the issue of financial toxicity in cancer: a systematic review of the literature","volume":"44","author":"Sideris","year":"2025","journal-title":"J Cancer Policy"},{"issue":"12","key":"10.1016\/j.vhri.2026.101689_bib34","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1016\/S1470-2045(21)00468-X","article-title":"Financial toxicity in cancer care in India: a systematic review","volume":"22","author":"Boby","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vhri.2026.101689_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1266533","article-title":"Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis","volume":"11","author":"Azzani","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.vhri.2026.101689_bib36","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/OP.24.00162","article-title":"Financial toxicity has never been more important in cancer care: how do we measure it?","volume":"21","author":"Hlubocky","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"12","key":"10.1016\/j.vhri.2026.101689_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.vhri.2026.101689_bib40","author":"Thomson"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12913-021-06330-6","article-title":"Incidence of household catastrophic and impoverishing health expenditures among patients with Breast Cancer in Iran","volume":"21","author":"Ahmadi","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.vhri.2026.101689_bib45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.31557\/APJCP.2023.24.2.489","article-title":"The direct and indirect costs of cancer among the lower-income group: estimates from a pilot and feasibility study","volume":"24","author":"Aminuddin","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"10.1016\/j.vhri.2026.101689_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311815","article-title":"Cancer impact on lower-income patients in Malaysian public healthcare: an exploration of out-of-pocket expenses, productivity loss, and financial coping strategies","volume":"19","author":"Aminuddin","year":"2024","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib47","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1186\/s12889-025-23415-7","article-title":"The economic toll of cancer: catastrophic expenditure and impoverishment among lower-income households in Malaysia","volume":"25","author":"Aminuddin","year":"2025","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.vhri.2026.101689_bib48","first-page":"621","article-title":"Out-of-pocket medical costs in relation to resection of colorectal liver metastases in the Australian healthcare system","volume":"33","author":"Bhimani","year":"2025","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/curroncol28010005","article-title":"Out-of-pocket costs and perceived financial burden associated with prostate cancer treatment in a Quebec remote area: a cross-sectional study","volume":"28","author":"El-Haouly","year":"2021","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044322","article-title":"Effects of cancer treatment on household impoverishment: a multicentre cross-sectional study in China","volume":"11","author":"Fu","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.vhri.2026.101689_bib51","article-title":"Direct and indirect costs of breast cancer management in sub-Saharan Africa","volume":"45","author":"Konga","year":"2025","journal-title":"J Cancer Policy"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib52","first-page":"3377","article-title":"Patient and family financial burden associated with cancer treatment in Canada: a national study","volume":"29","author":"Longo","year":"2021","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13104-021-05814-2","article-title":"Costs incurred by patients with oral potentially malignant disorders: is there a public health need for financial protection in India?","volume":"14","author":"Patel","year":"2021","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vhri.2026.101689_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1065737","article-title":"Financial toxicity of cancer treatment in India: towards closing the cancer care gap","volume":"11","author":"Prinja","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.vhri.2026.101689_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.779285","article-title":"Socio-economic and rural-urban differences in healthcare and catastrophic health expenditure among cancer patients in China: analysis of the China health and retirement longitudinal study","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.vhri.2026.101689_bib56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/CEOR.S367458","article-title":"The burden of a multiple myeloma diagnosis on patients and caregivers in the first year: Western European findings","volume":"14","author":"Gatopoulou","year":"2022","journal-title":"Clin Outcomes Res"},{"issue":"7","key":"10.1016\/j.vhri.2026.101689_bib57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/onco.13767","article-title":"Patient-reported out-of-pocket costs and financial toxicity during early-phase oncology clinical trials","volume":"26","author":"Huey","year":"2021","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib58","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.31557\/APJCP.2025.26.6.2035","article-title":"Catastrophic health expenditure and its associated factors among adult cancer patients in a teaching hospital in East Coast of Malaysia","volume":"26","author":"Kamarul Zaman","year":"2025","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"10.1016\/j.vhri.2026.101689_bib59","article-title":"Out-of-pocket costs associated with head and neck cancer treatment. Cancer rep","volume":"5","author":"Khan","year":"2021","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.vhri.2026.101689_bib60","doi-asserted-by":"crossref","first-page":"272","DOI":"10.11604\/pamj.2022.41.272.24610","article-title":"The out-of-pocket cost of breast cancer care at a public tertiary care hospital in Nigeria: an exploratory analysis","volume":"41","author":"Knapp","year":"2022","journal-title":"Pan Afr Med J"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12939-024-02215-2","article-title":"Catastrophic health expenditure and distress financing of breast cancer treatment in India: evidence from a longitudinal cohort study","volume":"23","author":"Mohanty","year":"2024","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.vhri.2026.101689_bib62","article-title":"Treatment cost and psychological impact of Burkitt lymphoma on Ghanaian families and caregivers","volume":"44","author":"Owusu","year":"2024","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12939-025-02421-6","article-title":"Out-of-pocket cost and financial catastrophe of patients with cancer: the alarming cost-of-illness in Bangladesh","volume":"24","author":"Sarker","year":"2025","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.vhri.2026.101689_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.704700","article-title":"Catastrophic health expenditure and its determinants among households with breast cancer patients in China: a multicentre, cross-sectional survey","volume":"9","author":"Sun","year":"2021","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib65","first-page":"515","article-title":"Assessment of financial toxicity in patients with cancer in Slovenia","volume":"33","author":"V\u00f6r\u00f6\u0161","year":"2025","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib66","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.31557\/APJCP.2023.24.6.1897","article-title":"Catastrophic health expenditure (CHE) among cancer population in a middle-income country with universal healthcare financing","volume":"24","author":"Wan Puteh","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7185","article-title":"Understanding the financial cost of cancer clinical trial participation","volume":"13","author":"Williams","year":"2024","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.vhri.2026.101689_bib68","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clml.2024.02.013","article-title":"Financial toxicity, time toxicity, and quality of life in multiple myeloma","volume":"24","author":"Banerjee","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib69","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf131","article-title":"The financial toll of cancer: uncovering the links between financial toxicity and symptom burden","volume":"30","author":"Filetti","year":"2025","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.vhri.2026.101689_bib70","doi-asserted-by":"crossref","DOI":"10.1590\/1806-9282.20241349","article-title":"The relationship of out-of-pocket expenses to quality of life and disease coping in breast cancer patients receiving chemotherapy","volume":"71","author":"G\u00fcvener","year":"2025","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib71","first-page":"14","article-title":"Does cancer treatment-related financial distress worsen over time?","volume":"82","author":"Hussaini","year":"2021","journal-title":"N C Med J"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib72","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4103\/ijmr.IJMR_4028_20","article-title":"Quality of life assessment & out-of-pocket expenditure in multiple myeloma: an observational study","volume":"154","author":"Mathew","year":"2021","journal-title":"Indian J Med Res"},{"issue":"10","key":"10.1016\/j.vhri.2026.101689_bib73","doi-asserted-by":"crossref","first-page":"e1450","DOI":"10.1200\/OP.20.00890","article-title":"Financial toxicity of cancer care: an analysis of financial burden in three distinct health care systems","volume":"17","author":"Parikh","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"10.1016\/j.vhri.2026.101689_bib74","first-page":"264","article-title":"Financial toxicity assessment and associated factors analysis of patients with cancer in China","volume":"31","author":"Qiu","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.vhri.2026.101689_bib75","article-title":"Financial toxicity among older Mexican adults with cancer and their families: a mixed-methods study","volume":"8","author":"S\u00e1nchez-Rom\u00e1n","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70891","article-title":"Financial toxicity among cancer patients in Slovenia","volume":"14","author":"Skubic","year":"2025","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.vhri.2026.101689_bib77","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.3390\/curroncol30050371","article-title":"Financial toxicity and out-of-pocket costs for patients with head and neck cancer","volume":"30","author":"Smith","year":"2023","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.vhri.2026.101689_bib78","doi-asserted-by":"crossref","first-page":"740","DOI":"10.25259\/JNRP-2022-3-45","article-title":"Quality of life, out-of-pocket expenditures, and indirect costs among patients with the central nervous system tumors in Thailand","volume":"13","author":"Tunthanathip","year":"2022","journal-title":"J Neurosci Rural Pract"},{"issue":"6","key":"10.1016\/j.vhri.2026.101689_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105293","article-title":"Financial toxicity and socioeconomic impact of cancer in Europe","volume":"10","author":"Vancoppenolle","year":"2025","journal-title":"ESMO Open"},{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70799","article-title":"Risk factors for financial toxicity in patients with pancreatic cancer","volume":"14","author":"Wang","year":"2025","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib81","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.3390\/ijerph19084500","article-title":"Equity in out-of-pocket payments for healthcare services: evidence from Malaysia","volume":"19","author":"Baharin","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vhri.2026.101689_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1594542","article-title":"Understanding out-of-pocket expenditure in India: a systematic review","volume":"13","author":"Kamath","year":"2025","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.vhri.2026.101689_bib83","first-page":"e622","article-title":"The direct and indirect financial costs of informal cancer care: a scoping review","volume":"27","author":"Coumoundouros","year":"2019","journal-title":"Health Soc Care Community"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib84","article-title":"Standardizing survey data collection to enhance reproducibility: development and comparative evaluation of the ReproSchema ecosystem","volume":"27","author":"Chen","year":"2025","journal-title":"J Med Internet Res"},{"issue":"7","key":"10.1016\/j.vhri.2026.101689_bib85","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40273-013-0055-4","article-title":"Cost of illness in colorectal cancer: an international review","volume":"31","author":"Kriza","year":"2013","journal-title":"Pharmacoeconomics"},{"issue":"20","key":"10.1016\/j.vhri.2026.101689_bib86","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"de Souza","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib88","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2020.1865625","article-title":"Adaptation of WHO\u2019s generic tuberculosis patient cost instrument for a longitudinal study in Africa","volume":"14","author":"Evans","year":"2021","journal-title":"Glob Health Action"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-56594-1","article-title":"Catastrophic costs incurred by tuberculosis affected households from Thailand\u2019s first national tuberculosis patient cost survey","volume":"14","author":"Youngkong","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib90","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: a guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vhri.2026.101689_bib91","author":"Pezzullo"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib92","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1186\/s12913-025-13503-0","article-title":"Assessing the financial burden on patients and their households attending hospital clinics: a pilot cross-sectional study","volume":"25","author":"Rabbitt","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"10.1016\/j.vhri.2026.101689_bib93","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/healthcare10102099","article-title":"The burden of out-of-pocket expenditure related to gynaecological cancer in Malaysia","volume":"10","author":"Liew","year":"2022","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"10.1016\/j.vhri.2026.101689_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12178-025-09998-z","article-title":"Validating patient-reported outcomes and surveys in other languages","volume":"19","author":"Kwok","year":"2025","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"2","key":"10.1016\/j.vhri.2026.101689_bib96","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1093\/pubmed\/fdae220","article-title":"Income inequality, healthcare services and quality of life: how socio-economically disadvantaged Filipinos thrive?","volume":"47","author":"Rogayan","year":"2025","journal-title":"J Public Health (Oxf)"},{"issue":"8","key":"10.1016\/j.vhri.2026.101689_bib97","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-017859","article-title":"The socioeconomic and health system determinants of financial protection indicators: a global systematic review (2008-2023)","volume":"10","author":"Guo","year":"2025","journal-title":"BMJ Glob Health"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:38:51Z","timestamp":1790368731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":92,"alternative-id":["S2212109926001044"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101689","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey and Patient-Reported Outcome Measure Instruments for Assessing Out-of-Pocket Costs and Financial Toxicity in Cancer Care: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101689"}}